Wave Life Sciences
WVE
Wave Life Sciences (WVE) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.34
- EPS estimate
- −$0.30
- EPS surprise
- −12.40%
- Revenue surprise
- −65.22%
- Revenue
- $2.3M
- Revenue estimate
- $6.5M
- Reported
- Jul 30, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | −$0.30 | −$0.34 | −12.40% | $2.3M | SEC |
| Q1 2026 | Apr 28, 2026 | −$0.32 | −$0.13 | +59.81% | $38.2M | SEC |
| Q4 2025 | Feb 26, 2026 | −$0.27 | −$0.30 | −9.57% | $17.2M | SEC |
| Q3 2025 | Nov 10, 2025 | −$0.30 | −$0.32 | −5.19% | $7.6M | SEC |
| Q2 2025 | Jul 30, 2025 | −$0.28 | −$0.31 | −11.79% | $8.7M | SEC |
| Q1 2025 | May 8, 2025 | −$0.26 | −$0.29 | −11.75% | $9.2M | SEC |
| Q4 2024 | Mar 4, 2025 | −$0.18 | $0.18 | +200.67% | $83.7M | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.28 | −$0.47 | −66.20% | −$7.7M | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.21 | −$0.25 | −20.54% | $19.7M | SEC |
| Q1 2024 | May 9, 2024 | −$0.19 | −$0.24 | −29.03% | $12.5M | SEC |
| Q4 2023 | Mar 6, 2024 | −$0.23 | −$0.15 | +33.83% | $29.1M | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.18 | $0.07 | +139.26% | $49.2M | SEC |
| Q2 2023 | Aug 3, 2023 | −$0.33 | −$0.20 | +39.65% | $22.1M | SEC |
| Q1 2023 | May 3, 2023 | −$0.04 | −$0.27 | −575.00% | $12.9M | SEC |
| Q4 2022 | Mar 22, 2023 | −$0.41 | −$0.47 | −14.63% | $1.2M | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.50 | −$0.42 | +15.44% | $285,000.00 | SEC |
| Q2 2022 | Aug 11, 2022 | −$0.51 | −$0.62 | −21.16% | $375,000.00 | SEC |
| Q1 2022 | May 12, 2022 | −$0.54 | −$0.62 | −14.52% | $1.8M | SEC |
| Q4 2021 | Mar 3, 2022 | −$0.52 | −$0.61 | −16.66% | $1.8M | SEC |
| Q3 2021 | Nov 10, 2021 | −$0.60 | −$0.12 | +80.05% | $36.4M | SEC |
Quarterly revenue
Frequently asked questions
When did Wave Life Sciences (WVE) last report earnings?
Wave Life Sciences last reported on Jul 30, 2026, covering fiscal Q2 2026.
Did WVE beat earnings estimates?
No. Wave Life Sciences reported EPS of −$0.34 for Q2 2026 against a −$0.30 estimate — a 12.40% miss.
How much revenue did WVE report last quarter?
Wave Life Sciences reported $2.3M in revenue for Q2 2026, against a consensus estimate of $6.5M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.